Targeted Molecular Treatments in Non-Small Cell Lung Cancer: A Clinical Guide for Oncologists

Targeted molecular treatments have changed the way non-small cell lung cancer (NSCLC) is managed. Epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), v-raf murine sarcoma viral oncogene homolog B1 (BRAF), and c-ros oncogene 1 (ROS1) mutations are now used to guide specific ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Bui, Kim Tam, Cooper, Wendy A., Kao, Steven, Boyer, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111731/
https://www.ncbi.nlm.nih.gov/pubmed/30065223
http://dx.doi.org/10.3390/jcm7080192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111731/
https://www.ncbi.nlm.nih.gov/pubmed/30065223
http://dx.doi.org/10.3390/jcm7080192

Ejemplares similares